Cargando…
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
BACKGROUND: The COVID-19 vaccines are currently recommended for people with rare neuroimmunological diseases such as neuromyelitis optica spectrum disorder (NMOSD), MOG-antibody disease (MOGAD), and transverse myelitis. However, the safety profile of the vaccines in this population is uncertain. OBJ...
Autores principales: | Lotan, Itay, Romanow, Gabriela, Levy, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327627/ https://www.ncbi.nlm.nih.gov/pubmed/34375861 http://dx.doi.org/10.1016/j.msard.2021.103189 |
Ejemplares similares
-
Vaccination and immunotherapies in neuroimmunological diseases
por: Winkelmann, Alexander, et al.
Publicado: (2022) -
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
por: Lotan, Itay, et al.
Publicado: (2022) -
Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology
por: Robinson-Agramonte, María de los Angeles, et al.
Publicado: (2018) -
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
por: Lotan, Itay, et al.
Publicado: (2023) -
COVID-19 and management of neuroimmunological disorders
por: Hartung, Hans-Peter, et al.
Publicado: (2020)